Dear Shareholders,
On 17th August, 1935, our founder, Dr K A Hamied,
established the Chemical, Industrial & Pharmaceutical Laboratories Ltd. with a vision,
determination and a deep empathy for humanity. The company was later renamed 'Cipla'. Over
the decades, Cipla has provided access to affordable, high-quality medicines - not only in
India, but globally.
Today, Cipla remains fully committed to its purpose of 'Caring for
Life'.
In 2025, we proudly complete nine decades of service to society.
Throughout this journey, Cipla has consistently prioritised science, R&D and
innovation, while maintaining a humanitarian approach to its business. From humble
beginnings, Cipla has grown into one of India's leading pharmaceutical companies. Our
purpose reflects our core belief, "Success does not make a company great. What really
matters is its contribution to society and improving the lives of our fellowmen."
The Cipla journey has travelled side by side with my own life, as I
will soon turn 90 in mid-2026.1 have been involved with the Company virtually since
inception. It has been a long and arduous association, but at the same time very fruitful.
In all humility,
I feel extremely proud of my years in Cipla and my own personal role in
Cipla's evolution.
There are two words I would like to share with everyone. The first is
"Imagination", a quality that differentiates people, especially scientists. The
second and perhaps more important, is "Enthusiasm", the
passion for what one is pursuing in life, is what really matters. Even
after nearly 70 years in the pharmaceutical industry, I am still deeply enthusiastic,
particularly in the areas of R&D, new product launches and future innovations. All of
this is aimed towards Cipla's progress and growth, as also to help communities and
alleviate the sufferings of patients.
Cipla's endeavour has always been 'Caring for Life' and therefore, each
one of you, our shareholders, indirectly contribute to this mission.
Our respiratory portfolio helps millions breathe freely. The
anti-retroviral drugs made by us have saved innumerable lives of those suffering from
HIV/AIDS, essentially in Africa. Cipla provides care when there is no cure. Via its
Palliative Care initiatives, Cipla has supported thousands of patients and their families
in India over the past three decades. I would like to reiterate that Cipla's purpose is
not only business-driven, but also has a humanitarian approach. We strive to make a
meaningful impact towards the healthcare needs of society.
We want to contribute to newer technologies, advanced medication, so
that we can expand our product portfolio to enable a better quality of life for everyone.
The intrinsic strength of Cipla lies in its people, both past and
present.
From a small team in our early years, we now have a global workforce of
nearly 30,000. I feel proud to share that the dedication, passion, resilience and sense of
purpose shown by one and all, has been ongoing over the years and we all uphold the strong
values on which our Company has been built. The accomplishments we have achieved so far
are a testament to the unwavering support we have received, both in the past and present,
as also the collaborative spirit of all our partners including the
invaluable support that we continue to receive from the medical
community and pharmacies. We also have to acknowledge the strategic guidance of our
Company's Management team, the Cipla Board of Directors and above all, the trust and faith
our shareholders have in our Company.
To one and all, I extend my personal appreciation, as also that of
Cipla.
We have come a long way from a modest beginning in 1935 to becoming a
leading international pharmaceutical company. Cipla will continue to pioneer, innovate,
care and contribute to the welfare of all. Hopefully, Cipla will preserve and uphold its
legacy in the years ahead and continue its strategic progress and growth in the future.
I would like to express my deepest gratitude to Mr M K Hamied, whose
visionary leadership has been instrumental in shaping Cipla's journey. Mr Hamied played a
pivotal role in steering Cipla's progress and though he has formally retired, he continues
to offer invaluable guidance on humanitarian matters. On behalf of everyone at Cipla, we
extend our heartfelt thanks to him and wish him continued good health and well-being
Finally, I would like to thank each one of you, our shareholders and
the Cipla family for being part of our ongoing journey.
Warm regards,